Global Market Report

Global Induced Pluripotent Stem Cells Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Nov 10, 2018
  • PAGES：203
  • REPORT CODE：GMM123875
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Induced Pluripotent Stem Cells witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Induced Pluripotent Stem Cells market is offered. The research provides insights for the global Induced Pluripotent Stem Cells market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Induced Pluripotent Stem Cells industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Induced Pluripotent Stem Cells Market Segmentations:

    By Players:

    • Iperian

    • Cellectics

    • Fate Therapeutics

    • Lonza

    • Cellular Dynamics

    • Waisman Biomanufacturing

    • Axiogenesis

    • Reprocell

    • Viacyte

    • Medipost Co. Ltd.

    • System Biosciences

    • Stemgent

    • Organogenesis Inc.

    • BrainStorm Cell Therapeutics Inc.

    • Regeneus Ltd.

    • Bone Therapeutics SA

    • CellTherapies P/L

    • Ocata Therapeutics Inc.


    By Types:

    • Adult Sources

    • Fetal Sources

    • Others


    By End-User:

    • Hematopoietic stem cell transplantation

    • Tissue repair damage

    • Autoimmune diseases

    • As gene therapy vectors.


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Induced Pluripotent Stem Cells Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Induced Pluripotent Stem Cells Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Induced Pluripotent Stem Cells Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Induced Pluripotent Stem Cells Market Share by Types

      • 1.3.2 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Adult Sources from 2013 to 2025

      • 1.3.3 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Fetal Sources from 2013 to 2025

      • 1.3.4 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Others from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Induced Pluripotent Stem Cells Market Share by End-Users

      • 1.4.2 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation from 2013 to 2025

      • 1.4.3 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Tissue repair damage from 2013 to 2025

      • 1.4.4 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Autoimmune diseases from 2013 to 2025

      • 1.4.5 Global Induced Pluripotent Stem Cells Market Size and Growth Rate of As gene therapy vectors. from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumInduced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Induced Pluripotent Stem Cells Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Induced Pluripotent Stem Cells by Major Types

      • 3.4.1 Market Size and Growth Rate of Adult Sources

      • 3.4.2 Market Size and Growth Rate of Fetal Sources

      • 3.4.3 Market Size and Growth Rate of Others


    4 Segmentation of Induced Pluripotent Stem Cells Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Induced Pluripotent Stem Cells by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Induced Pluripotent Stem Cells for Hematopoietic stem cell transplantation

      • 4.4.2 Market Size and Growth Rate of Induced Pluripotent Stem Cells for Tissue repair damage

      • 4.4.3 Market Size and Growth Rate of Induced Pluripotent Stem Cells for Autoimmune diseases

      • 4.4.4 Market Size and Growth Rate of Induced Pluripotent Stem Cells for As gene therapy vectors.


    5 Market Analysis by Major Regions

    • 5.1 Global Induced Pluripotent Stem Cells Production Analysis by Major Regions

    • 5.2 Global Induced Pluripotent Stem Cells Consumption Analysis by Major Regions

    • 5.3 Global Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis


    6 Product Commodity of Induced Pluripotent Stem Cells Market in Major Countries

    • 6.1 Top 5 Export Countries in Induced Pluripotent Stem Cells market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Induced Pluripotent Stem Cells market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Induced Pluripotent Stem Cells Landscape Analysis

    • 7.1 North America Induced Pluripotent Stem Cells Landscape Analysis by Major Types

    • 7.2 North America Induced Pluripotent Stem Cells Landscape Analysis by Major End-Users

    • 7.3 North America Induced Pluripotent Stem Cells Landscape Analysis by Major Countries

      • 7.3.1 United States Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 7.3.2 Canada Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 7.3.3 Mexico Induced Pluripotent Stem Cells Market Volume and Growth Rate


    8 Europe Induced Pluripotent Stem Cells Landscape Analysis

    • 8.1 Europe Induced Pluripotent Stem Cells Landscape Analysis by Major Types

    • 8.2 Europe Induced Pluripotent Stem Cells Landscape Analysis by Major End-Users

    • 8.3 Europe Induced Pluripotent Stem Cells Landscape Analysis by Major Countries

      • 8.3.1 Germany Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.2 UK Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.3 France Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.4 Italy Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.6 Spain Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.7 Belgium Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.8 Poland Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.9 Russia Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 8.3.10 Turkey Induced Pluripotent Stem Cells Market Volume and Growth Rate


    9 Asia Pacific Induced Pluripotent Stem Cells Landscape Analysis

    • 9.1 Asia Pacific Induced Pluripotent Stem Cells Landscape Analysis by Major Types

    • 9.2 Asia Pacific Induced Pluripotent Stem Cells Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Induced Pluripotent Stem Cells Landscape Analysis by Major Countries

      • 9.3.1 China Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 9.3.2 Japan Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 9.3.4 India Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 9.3.6 South Korea Induced Pluripotent Stem Cells Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Induced Pluripotent Stem Cells Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 10.3.2 Brazil Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 10.3.3 Nigeria Induced Pluripotent Stem Cells Market Volume and Growth Rate

      • 10.3.4 South Africa Induced Pluripotent Stem Cells Market Volume and Growth Rate 

      • 10.3.5 Argentina Induced Pluripotent Stem Cells Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Iperian

      • 11.1.1 Iperian Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Cellectics

      • 11.2.1 Cellectics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Fate Therapeutics

      • 11.3.1 Fate Therapeutics Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Lonza

      • 11.4.1 Lonza Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cellular Dynamics

      • 11.5.1 Cellular Dynamics Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Waisman Biomanufacturing

      • 11.6.1 Waisman Biomanufacturing Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Axiogenesis

      • 11.7.1 Axiogenesis Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Reprocell

      • 11.8.1 Reprocell Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Viacyte

      • 11.9.1 Viacyte Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Medipost Co. Ltd.

      • 11.10.1 Medipost Co. Ltd. Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 System Biosciences

      • 11.11.1 System Biosciences Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Stemgent

      • 11.12.1 Stemgent Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Organogenesis Inc.

      • 11.13.1 Organogenesis Inc. Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 BrainStorm Cell Therapeutics Inc.

      • 11.14.1 BrainStorm Cell Therapeutics Inc. Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Regeneus Ltd.

      • 11.15.1 Regeneus Ltd. Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Bone Therapeutics SA

      • 11.16.1 Bone Therapeutics SA Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 CellTherapies P/L

      • 11.17.1 CellTherapies P/L Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Ocata Therapeutics Inc.

      • 11.18.1 Ocata Therapeutics Inc. Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 84 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Adult Sources from 2013 to 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Fetal Sources from 2013 to 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Others from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation from 2013 to 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Tissue repair damage from 2013 to 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of Autoimmune diseases from 2013 to 2025

    • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate of As gene therapy vectors. from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Induced Pluripotent Stem Cells Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Induced Pluripotent Stem Cells Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Induced Pluripotent Stem Cells

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Induced Pluripotent Stem Cells by Different Types from 2013 to 2025

    • Table Consumption Share of Induced Pluripotent Stem Cells by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Adult Sources

    • Figure Market Size and Growth Rate of Fetal Sources

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Induced Pluripotent Stem Cells by Different End-Users from 2013 to 2025

    • Table Consumption Share of Induced Pluripotent Stem Cells by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Hematopoietic stem cell transplantation

    • Figure Market Size and Growth Rate of Tissue repair damage

    • Figure Market Size and Growth Rate of Autoimmune diseases

    • Figure Market Size and Growth Rate of As gene therapy vectors.

    • Table Global Induced Pluripotent Stem Cells Production by Major Regions

    • Table Global Induced Pluripotent Stem Cells Production Share by Major Regions

    • Figure Global Induced Pluripotent Stem Cells Production Share by Major Regions in 2013

    • Figure Global Induced Pluripotent Stem Cells Production Share by Major Regions in 2018

    • Figure Global Induced Pluripotent Stem Cells Production Share by Major Regions in 2025

    • Table Global Induced Pluripotent Stem Cells Consumption by Major Regions

    • Table Global Induced Pluripotent Stem Cells Consumption Share by Major Regions

    • Figure Global Induced Pluripotent Stem Cells Consumption Share by Major Regions in 2013

    • Figure Global Induced Pluripotent Stem Cells Consumption Share by Major Regions in 2018

    • Figure Global Induced Pluripotent Stem Cells Consumption Share by Major Regions in 2025

    • Table North America Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

    • Table Europe Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Induced Pluripotent Stem Cells market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Induced Pluripotent Stem Cells Consumption by Types from 2013 to 2025

    • Table North America Induced Pluripotent Stem Cells Consumption Share by Types from 2013 to 2025

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Types in 2013

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Types in 2018

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Types in 2025

    • Table North America Induced Pluripotent Stem Cells Consumption by End-Users from 2013 to 2025

    • Table North America Induced Pluripotent Stem Cells Consumption Share by End-Users from 2013 to 2025

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by End-Users in 2013

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by End-Users in 2018

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by End-Users in 2025

    • Table North America Induced Pluripotent Stem Cells Consumption by Major Countries from 2013 to 2025

    • Table North America Induced Pluripotent Stem Cells Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2013

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2018

    • Figure North America Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2025

    • Figure United States Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption by Types from 2013 to 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption Share by Types from 2013 to 2025

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Types in 2013

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Types in 2018

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Types in 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption by End-Users from 2013 to 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by End-Users in 2013

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by End-Users in 2018

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by End-Users in 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption by Major Countries from 2013 to 2025

    • Table Europe Induced Pluripotent Stem Cells Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2013

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2018

    • Figure Europe Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2025

    • Figure Germany Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure France Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption by Types from 2013 to 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Types in 2013

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Types in 2018

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Types in 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by End-Users in 2013

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by End-Users in 2018

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by End-Users in 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2025

    • Figure China Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandInduced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure India Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Induced Pluripotent Stem Cells Consumption Share by Major Countries in 2025

    • Figure GCC Countries Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Induced Pluripotent Stem Cells Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Iperian

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iperian

    • Figure Sales and Growth Rate Analysis of Iperian

    • Figure Revenue and Market Share Analysis of Iperian

    • Table Product and Service Introduction of Iperian

    • Table Company Profile and Development Status of Cellectics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectics

    • Figure Sales and Growth Rate Analysis of Cellectics

    • Figure Revenue and Market Share Analysis of Cellectics

    • Table Product and Service Introduction of Cellectics

    • Table Company Profile and Development Status of Fate Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fate Therapeutics

    • Figure Sales and Growth Rate Analysis of Fate Therapeutics

    • Figure Revenue and Market Share Analysis of Fate Therapeutics

    • Table Product and Service Introduction of Fate Therapeutics

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Cellular Dynamics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellular Dynamics

    • Figure Sales and Growth Rate Analysis of Cellular Dynamics

    • Figure Revenue and Market Share Analysis of Cellular Dynamics

    • Table Product and Service Introduction of Cellular Dynamics

    • Table Company Profile and Development Status of Waisman Biomanufacturing

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Waisman Biomanufacturing

    • Figure Sales and Growth Rate Analysis of Waisman Biomanufacturing

    • Figure Revenue and Market Share Analysis of Waisman Biomanufacturing

    • Table Product and Service Introduction of Waisman Biomanufacturing

    • Table Company Profile and Development Status of Axiogenesis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Axiogenesis

    • Figure Sales and Growth Rate Analysis of Axiogenesis

    • Figure Revenue and Market Share Analysis of Axiogenesis

    • Table Product and Service Introduction of Axiogenesis

    • Table Company Profile and Development Status of Reprocell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reprocell

    • Figure Sales and Growth Rate Analysis of Reprocell

    • Figure Revenue and Market Share Analysis of Reprocell

    • Table Product and Service Introduction of Reprocell

    • Table Company Profile and Development Status of Viacyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Viacyte

    • Figure Sales and Growth Rate Analysis of Viacyte

    • Figure Revenue and Market Share Analysis of Viacyte

    • Table Product and Service Introduction of Viacyte

    • Table Company Profile and Development Status of Medipost Co. Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medipost Co. Ltd.

    • Figure Sales and Growth Rate Analysis of Medipost Co. Ltd.

    • Figure Revenue and Market Share Analysis of Medipost Co. Ltd.

    • Table Product and Service Introduction of Medipost Co. Ltd.

    • Table Company Profile and Development Status of System Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of System Biosciences

    • Figure Sales and Growth Rate Analysis of System Biosciences

    • Figure Revenue and Market Share Analysis of System Biosciences

    • Table Product and Service Introduction of System Biosciences

    • Table Company Profile and Development Status of Stemgent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stemgent

    • Figure Sales and Growth Rate Analysis of Stemgent

    • Figure Revenue and Market Share Analysis of Stemgent

    • Table Product and Service Introduction of Stemgent

    • Table Company Profile and Development Status of Organogenesis Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Organogenesis Inc.

    • Figure Sales and Growth Rate Analysis of Organogenesis Inc.

    • Figure Revenue and Market Share Analysis of Organogenesis Inc.

    • Table Product and Service Introduction of Organogenesis Inc.

    • Table Company Profile and Development Status of BrainStorm Cell Therapeutics Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BrainStorm Cell Therapeutics Inc.

    • Figure Sales and Growth Rate Analysis of BrainStorm Cell Therapeutics Inc.

    • Figure Revenue and Market Share Analysis of BrainStorm Cell Therapeutics Inc.

    • Table Product and Service Introduction of BrainStorm Cell Therapeutics Inc.

    • Table Company Profile and Development Status of Regeneus Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneus Ltd.

    • Figure Sales and Growth Rate Analysis of Regeneus Ltd.

    • Figure Revenue and Market Share Analysis of Regeneus Ltd.

    • Table Product and Service Introduction of Regeneus Ltd.

    • Table Company Profile and Development Status of Bone Therapeutics SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bone Therapeutics SA

    • Figure Sales and Growth Rate Analysis of Bone Therapeutics SA

    • Figure Revenue and Market Share Analysis of Bone Therapeutics SA

    • Table Product and Service Introduction of Bone Therapeutics SA

    • Table Company Profile and Development Status of CellTherapies P/L

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CellTherapies P/L

    • Figure Sales and Growth Rate Analysis of CellTherapies P/L

    • Figure Revenue and Market Share Analysis of CellTherapies P/L

    • Table Product and Service Introduction of CellTherapies P/L

    • Table Company Profile and Development Status of Ocata Therapeutics Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ocata Therapeutics Inc.

    • Figure Sales and Growth Rate Analysis of Ocata Therapeutics Inc.

    • Figure Revenue and Market Share Analysis of Ocata Therapeutics Inc.

    • Table Product and Service Introduction of Ocata Therapeutics Inc.


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US